Stock INTS INTENSITY THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Intensity Therapeutics, Inc.

Equities

INTS

US45828J1034

Market Closed - Nasdaq
Other stock markets
 04:30:01 2024-07-09 pm EDT 		5-day change 1st Jan Change
4.74 USD -0.42% Intraday chart for Intensity Therapeutics, Inc. -2.67% -44.69%
Jul. 09 Intensity Therapeutics, Inc. Announces First Patient Dosed in Its Global Randomized, Phase 3 Study (Invincible-3) in Metastatic Soft Tissue Sarcoma CI
Jul. 01 Intensity Therapeutics, Inc.(NasdaqCM:INTS) dropped from Russell Microcap Value Index CI

Evolution of the average Target Price on Intensity Therapeutics, Inc.

Price target over the last 5 years

History of analyst recommendation changes

b057ca5fad441075e20bc9c167e5bf7.3hOK7PsuqZe9jCVShtFc8uCCjv1PhUFf2_69s_uNal4.7nLdj4ob6q6KoXwY0ugKoqzu_akVzTsdk4_p9b_FDgGaee62inHz-tXccA~f23f08996ce8c861e644f2e990536b28

Analyst Recommendations on Intensity Therapeutics, Inc.

Benchmark Initiates Intensity Therapeutics at Speculative Buy With $12 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
4.74 USD
Average target price
12 USD
Spread / Average Target
+153.16%
High Price Target
12 USD
Spread / Highest target
+153.16%
Low Price Target
12 USD
Spread / Lowest Target
+153.16%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Intensity Therapeutics, Inc.

Benchmark Company

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. INTS Stock
  4. Consensus Intensity Therapeutics, Inc.